Reversal of social deficits by subchronic oxytocin in two autism mouse models-Reference-Cited by-同舟云学术

Reversal of social deficits by subchronic oxytocin in two autism mouse models

Published:2016-06 Issue: Volume:105 Page:61-71
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Teng Brian L.^ORCID,Nikolova Viktoriya D.,Riddick Natallia V.,Agster Kara L.,Crowley James J.,Baker Lorinda K.^ORCID,Koller Beverly H.,Pedersen Cort A.,Jarstfer Michael B.,Moy Sheryl S.

Funder

Department of Defense

National Institute for Mental Health

National Institute of Child Health & Human Development

Autism Speaks Translational Postdoctoral Fellowship

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference71 articles.

1. Advances in autism genetics: on the threshold of a new neurobiology;Abrahams;Nat. Rev. Genet.,2008

2. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial;Anagnostou;Mol. Autism,2012

3. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders;Andari;Proc. Natl. Acad. Sci. U. S. A.,2010

4. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles;Bales;Biol. Psychiatry,2013

5. Long-term exposure to intranasal oxytocin in a mouse autism model;Bales;Transl. Psychiatry,2014

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA‐sequencing reveals a shared neurotranscriptomic profile in the medial preoptic area of highly social songbirds and rats;Genes, Brain and Behavior;2024-07-25

2. Acute, chronic and conditioned effects of intranasal oxytocin in the mu-opioid receptor knockout mouse model of autism: Social context matters;Neuropsychopharmacology;2024-07-17

3. Transcriptome analysis identifies an ASD-Like phenotype in oligodendrocytes and microglia from C58/J amygdala that is dependent on sex and sociability;Behavioral and Brain Functions;2024-06-19

4. The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder;Neuropharmacology;2024-05

5. Acute, chronic and conditioned effects of intranasal oxytocin in the mu opioid receptor knockout mouse model of autism: social context matters;2024-03-10